Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lerner

Showing results (311-320 of 375) with videos related to

Pageof 38
Sort By:
Stroke|September 29, 2017
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Tanzila Shams, Alexander P Auchus, Suzanne Oparil, et al.
American Journal of Human Genetics|August 1, 1997
Spectrum of mutations in the Batten disease gene, CLN3P B Munroe, H M Mitchison, A M O'Rawe, et al.
Trials|January 20, 2018
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trialRoberta W Scherer, Lea Drye, Jacobo Mintzer, et al.
Neuroradiology|January 6, 2021
Changes in brain functional connectivity and cognition related to white matter lesion burden in hypertensive patients from SPRINTChintan Shah, Dhivya Srinivasan, Guray Erus, et al.
Journal of the American Geriatrics Society|September 20, 2016
Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention TrialDan R Berlowitz, Tonya Breaux-Shropshire, Capri G Foy, et al.
Acta Neuropathologica Communications|April 8, 2021
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodiesConnor Bargar, Wen Wang, Steven A Gunzler, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2008
Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f)Torsten K Roepke, Andrianos Kontogeorgis, Christopher Ovanez, et al.
Neuropediatrics|February 1, 1997
Structure of the CLN3 gene and predicted structure, location and function of CLN3 proteinH M Mitchison, P E Taschner, G Kremmidiotis, et al.
American Journal of Human Genetics|May 20, 1999
Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorderD E Sleat, R M Gin, I Sohar, et al.
Pageof 38

Showing results (311-320 of 375) with videos related to

Sort By:
Pageof 38
Stroke|September 29, 2017
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Tanzila Shams, Alexander P Auchus, Suzanne Oparil, et al.
American Journal of Human Genetics|August 1, 1997
Spectrum of mutations in the Batten disease gene, CLN3P B Munroe, H M Mitchison, A M O'Rawe, et al.
Trials|January 20, 2018
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trialRoberta W Scherer, Lea Drye, Jacobo Mintzer, et al.
Neuroradiology|January 6, 2021
Changes in brain functional connectivity and cognition related to white matter lesion burden in hypertensive patients from SPRINTChintan Shah, Dhivya Srinivasan, Guray Erus, et al.
Journal of the American Geriatrics Society|September 20, 2016
Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention TrialDan R Berlowitz, Tonya Breaux-Shropshire, Capri G Foy, et al.
Acta Neuropathologica Communications|April 8, 2021
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodiesConnor Bargar, Wen Wang, Steven A Gunzler, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2008
Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f)Torsten K Roepke, Andrianos Kontogeorgis, Christopher Ovanez, et al.
Neuropediatrics|February 1, 1997
Structure of the CLN3 gene and predicted structure, location and function of CLN3 proteinH M Mitchison, P E Taschner, G Kremmidiotis, et al.
American Journal of Human Genetics|May 20, 1999
Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorderD E Sleat, R M Gin, I Sohar, et al.
Pageof 38